Fatty acid conjugation enhances the activities of antimicrobial peptides

Area of Science:

• Biochemistry
• Immunology
• Drug Discovery

Background:

• Antimicrobial peptides (AMPs) are vital for innate immunity, acting as a first line of defense against pathogens.
• Increasing antibiotic resistance necessitates novel therapeutic strategies, with AMPs emerging as promising candidates due to their broad-spectrum activity.
• Recent patents highlight the modification of AMPs, particularly through fatty acid conjugation, to improve their efficacy.

Purpose of the Study:

• To review recent patents on antimicrobial peptides modified with fatty acid conjugation.
• To explore how fatty acid conjugation modulates the potency, selectivity, and membrane interaction of antimicrobial peptides.
• To assess the potential of these modified AMPs as future therapeutic agents and food additives.

Main Methods:

• Review of recent patent literature concerning antimicrobial peptides and fatty acid conjugation.
• Analysis of how variable fatty acid tail lengths influence peptide-membrane interactions and activity.
• Investigation of the impact of critical micelle concentration (CMC) on peptide binding to cell membranes.

Main Results:

• Fatty acid conjugation significantly enhances the activity of antimicrobial peptides.
• This modification can render previously inactive peptides bioactive.
• The length of the fatty acid tail critically affects peptide potency, selectivity, and membrane interaction.
• Self-assembly above CMC can impede peptide binding to cell membranes.

Conclusions:

• Fatty acid conjugation is a promising strategy to improve antimicrobial peptide efficacy against resistant pathogens.
• Modified AMPs demonstrate potential for development into novel medicines and safe food additives.
• Further research into AMPs and their modifications is crucial for combating the growing threat of antimicrobial resistance.